Theodore S. Lawrence, M.D., Ph.D., The Max Wicha, M.D. Distinguished Chair of Oncology, is Director of the University of Michigan Comprehensive Cancer Center and the Chair of the Department of Radiation Oncology at the University of Michigan. He is Immediate Past President of the Radiation Oncology Institute. He is also a member of the Board of Scientific Advisors of the National Cancer Institute and a member of the National Academy of Medicine.
Lawrence is an editor for Translational Oncology, The Cancer Journal, Seminars in Radiation Oncology and Cancer Research. He has been President of the American Society of Radiation Oncology (ASTRO) and of the Society of Chairs of Academic Radiation Oncology Programs, Chair of the National Cancer Institute Board of Scientific Councilors, a member of the Board of Directors of the American Society of Clinical Oncology (ASCO), and Chair of the Radiation Sciences and Medicine Working Group (AACR). Additionally, he has been awarded the ASTRO Gold Medal, the highest award conferred by the society, and an ASCO Statesman Award.
Lawrence’s interests in the laboratory are focused on chemotherapeutic and molecularly targeted radiosensitizers. His clinical research combines these laboratory studies with conformal radiation guided by metabolic and functional imaging for the treatment of patients with gastrointestinal and central nervous system malignancies.
Lawrence joined the faculty of the University of Michigan in 1987, following a fellowship in medical oncology and a residency in radiation oncology at the National Cancer Institute. He received a joint medical and doctoral degree (cell biology) from the Cornell University Medical College/Rockefeller University and an internal medicine residency at Stanford University.